ICAM1 and myeloid sarcoma: EVs derived from T cells containing chemokine CCL5 and arachidonic acid can increase the expression of intercellular adhesion molecule 1 (ICAM-1) on endothelial cells and of Mac-1 on monocytes, contributing to the dysfunction of the BBB, leading to immune infiltration, a characteristic of MS pathogenesis (35–37).